Literature DB >> 18427163

Th17 cells and rheumatoid arthritis--from the standpoint of osteoclast differentiation--.

Kojiro Sato1.   

Abstract

Rheumatoid arthritis is a chronic disease that affects multiple joints. It is considered to be an autoimmune disease in which a T helper (Th)-1 type response has been implicated to play an important pathogenetic role. As osteoclasts, cells that resorb bone, play a crucial part in the bone destruction that occurs in RA, we and others have investigated the pathophysiology of these cells. The findings that interferon (IFN)-gamma strongly inhibits osteoclastogenesis and that interleukin (IL)-17 has the ability to enhance osteoclast differentiation have cast doubt on the hypothesis that RA is a Th1 disease. In this review, I describe the relationship between Th cells, the so-called "commander" of the immune response, and RA, mainly from the viewpoint of the environments Th cells create for the excessive differentiation and function of osteoclasts, resulting in the destruction of bone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427163     DOI: 10.2332/allergolint.R-07-158

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  16 in total

Review 1.  Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Authors:  Jennifer L Krauss; Jan Potempa; John D Lambris; George Hajishengallis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

2.  A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases.

Authors:  Michael Lyman; Vincent Lieuw; Robyn Richardson; Anjuli Timmer; Christine Stewart; Steve Granger; Richard Woods; Michela Silacci; Dragan Grabulovski; Roland Newman
Journal:  J Biol Chem       Date:  2018-04-20       Impact factor: 5.157

3.  A one-year evaluation of radiographic progression in patients with rheumatoid arthritis treated by Qingre Huoxue Decoction ().

Authors:  Quan Jiang; Xin-yao Zhou; Lei Wang; Wei Yu; Ping Wang; Wei Cao; Xiao-po Tang
Journal:  Chin J Integr Med       Date:  2011-08-18       Impact factor: 1.978

Review 4.  Does Aging Activate T-cells to Reduce Bone Mass and Quality?

Authors:  Rajeev Aurora; Deborah Veis
Journal:  Curr Osteoporos Rep       Date:  2022-08-31       Impact factor: 5.163

5.  Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes.

Authors:  Y Li; D Li; Y Li; S Wu; S Jiang; T Lin; L Xia; H Shen; J Lu
Journal:  Osteoporos Int       Date:  2015-11-16       Impact factor: 4.507

6.  MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients.

Authors:  Takuya Niimoto; Tomoyuki Nakasa; Masakazu Ishikawa; Atsushi Okuhara; Bunichiro Izumi; Masataka Deie; Osami Suzuki; Nobuo Adachi; Mitsuo Ochi
Journal:  BMC Musculoskelet Disord       Date:  2010-09-15       Impact factor: 2.362

7.  Protective effect of low-level laser therapy (LLLT) on acute zymosan-induced arthritis.

Authors:  Fernando Pereira Carlos; Marcelo de Paula Alves da Silva; Eliadna de Lemos Vasconcelos Silva Melo; Maricilia Silva Costa; Stella Regina Zamuner
Journal:  Lasers Med Sci       Date:  2013-08-10       Impact factor: 3.161

8.  Linking power Doppler ultrasound to the presence of th17 cells in the rheumatoid arthritis joint.

Authors:  Nicola J Gullick; Hayley G Evans; Leigh D Church; David M Jayaraj; Andrew Filer; Bruce W Kirkham; Leonie S Taams
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

9.  Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro.

Authors:  Zachary S Buchwald; Jennifer R Kiesel; Richard DiPaolo; Meghana S Pagadala; Rajeev Aurora
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

10.  TNFα promotes Th17 cell differentiation through IL-6 and IL-1β produced by monocytes in rheumatoid arthritis.

Authors:  Yingxia Zheng; Lei Sun; Ting Jiang; Dongqing Zhang; Dongyi He; Hong Nie
Journal:  J Immunol Res       Date:  2014-11-11       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.